NCT07138001 2025-08-22Phase 2 Clinical Trial of KH617Chengdu Kanghong Pharmaceutical Group Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT05844150 2025-03-12A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCBiotheus Inc.Phase 2 Active not recruiting50 enrolled
NCT00112346 2015-10-28Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerEli Lilly and CompanyPhase 2 Completed120 enrolled
NCT01844791 2014-10-21An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) PatientsOncozyme Pharma Inc.Phase 2 Completed25 enrolled